# Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

> **NCT06740383** · — · RECRUITING · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 320 (estimated)

## Conditions studied

- Schizophrenia Spectrum and Other Psychotic Disorders
- Schizophrenia
- Delusional Disorder
- Bipolar 1 Disorder
- Schizoaffective Disorder
- Psychosis Not Otherwise Specified
- Early Psychosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06740383
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06740383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06740383, "Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06740383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*